ClinicalMetric / Countries / Japan / metastatic hormone sensitive prostate cancer mhspc
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

metastatic hormone sensitive prostate cancer mhspc Clinical Trials in Japan

Active clinical trials for metastatic hormone sensitive prostate cancer mhspc with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT06661122
Recruiting

A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Enrollment
100 pts
Country
🇯🇵 Japan
Bayer
View Trial →

Frequently Asked Questions

How many metastatic hormone sensitive prostate cancer mhspc clinical trials are active in Japan?
There are currently 1 active clinical trials for metastatic hormone sensitive prostate cancer mhspc with sites in Japan, of which 1 are actively recruiting patients.
How can I join a metastatic hormone sensitive prostate cancer mhspc clinical trial in Japan?
To join a metastatic hormone sensitive prostate cancer mhspc clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are metastatic hormone sensitive prostate cancer mhspc trials in Japan?
Active metastatic hormone sensitive prostate cancer mhspc trials in Japan span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global metastatic hormone sensitive prostate cancer mhspc Trials → All Countries → All Trials →